IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,325 | +18.0% | 216,782 | +23.3% | 0.13% | -5.8% |
| Q4 2022 | $1,123 | -99.9% | 175,793 | +117.6% | 0.14% | +35.0% |
| Q3 2022 | $774,000 | -60.8% | 80,776 | -54.8% | 0.10% | -65.2% |
| Q2 2022 | $1,972,000 | +604.3% | 178,578 | +961.5% | 0.30% | +678.9% |
| Q1 2022 | $280,000 | -4.8% | 16,823 | +9.3% | 0.04% | +2.7% |
| Q4 2021 | $294,000 | +19.0% | 15,398 | +189.4% | 0.04% | -7.5% |
| Q4 2020 | $247,000 | +81.6% | 5,321 | -62.7% | 0.04% | +185.7% |
| Q1 2019 | $136,000 | -43.1% | 14,266 | -47.2% | 0.01% | -50.0% |
| Q4 2018 | $239,000 | – | 27,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |